ERBB2 and cancer: The frequencies of cancers positive for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2/Neu) were 4/31 (12.9%), 6/31 (19.4%) and 3/22 (13.6%), respectively.